Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial) - Université Pierre et Marie Curie Accéder directement au contenu
Article Dans Une Revue The Patient - Patient-Centered Outcomes Research Année : 2017

Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial)

Résumé

We aimed to compare health-related quality of life (HRQL) during and after hepatitis C virus (HCV) treatment in patients receiving pegylated-interferon (PEG-IFN)-containing therapy (including boceprevir or telaprevir-ANRS CO20 CUPIC cohort) who subsequently switched to PEG-IFN-free regimens (sofosbuvir + ledipasvir with or without ribavirin [RBV]-SIRIUS trial).
Fichier principal
Vignette du fichier
CarrieriProtopopescu_The Patient_HAL.pdf (271.78 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01767765 , version 1 (23-01-2023)

Identifiants

Citer

Maria Patrizia Carrieri, Camelia Protopopescu, Zobair Younossi, Antoine Vilotitch, Hélène Fontaine, et al.. Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial). The Patient - Patient-Centered Outcomes Research, 2017, 10 (5), pp.605 - 614. ⟨10.1007/s40271-017-0232-1⟩. ⟨hal-01767765⟩
219 Consultations
44 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More